Check for GLP-1 Agonist Use in Patients Admitted With Gallbladder Problems
October 2016
You'll hear more about a possible link between gallbladder disease and GLP-1 agonists...such as liraglutide (Victoza, etc) or exenatide (Byetta, etc).
The latest evidence suggests that about one in 357 patients taking liraglutide or exenatide over about 3 years will be hospitalized for bile duct or gallbladder disease...compared to patients on other diabetes meds.
We know that patients with diabetes already have a higher risk of bile duct and gallbladder disease. But GLP-1 agonists may increase this risk...possibly by causing rapid weight loss in some patients.
Get unlimited access through an Enterprise license
Hospital Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Not sold to individuals